prof. dr. Paul Jennings

Priv. Doz., BSc

  • De Boelelaan 1108, O|2 building. Room 03W51

    1081HZ Amsterdam


If you made any changes in Pure these will be visible here soon.

Personal profile


Links: PubmedGoogle ScholarResearch Gate




Research interests include: 

  • Development of improved human renal and hepatic in vitro models
  • Mechanistic understanding using integrated omic approaches in carefully designed exposure scenarios (transcriptomics, proteomics, metabolomics and epigenetics)
  • The understanding of how cells cope with stress and the delineation of stress response pathways, including oxidative stress (Nrf2), DNA damage (p53), hypoxia (HIF-1alpha) and the unfolded protein response.
  • Chemical-induced dedifferentiation and recovery after exposure
  • In vitro biokinetic studies
  • Integrating cheminformatics, kinetics and dynamics into computational systems toxicological models
  • Collaboration with specialists to build tiered integrated approaches for testing and assessment (IATA) / integrated testing systems (ITS) – (eg. BBB, liver, lung, brain, heart, skin) which are regulatory relevant (i.e. built with application to Adverse Outcome Pathways)
  • Understanding genetic diversity of dynamics and kinetics using iPSC.
  • Development of clinically-translational mechanistic biomarkers 

Teaching at the VU


Replacement Refinement and Reduction of Animal Experiments in Biomedical Research: From Origins to Implementation. XM_066


 Paul's Henry Stewart Talk contribution

 Jennings, P. (2016), "Molecular basis of genetic renal diseases 1 and 2", in The Biomedical & Life Sciences Collection, Henry Stewart Talks Ltd, London (online at )



In3: An integrated interdisciplinary approach to animal-free nanomaterial and chemical safety assessment.

OpenRiskNet: Open e-Infrastructure to Support Data Sharing, Knowledge Integration and in silico Analysis and Modelling in Risk Assessment

EUToxRisk: An Integrated EUropean ‘Flagship’ Program Driving Mechanism-based Toxicity Testing and Risk Assessment for the 21st Century

StemBANCC: Stem cells for Biological Assays of Novel drugs and predictive toxiCology

Personal information

Paul Jennings is the chair of the Division of Molecular and Computational Toxicology, VU, Amsterdam. His background is in epithelial and renal biology, in vitro cell culture system development and mechanistic toxicology. Paul hails from Dublin Ireland. He did his BSc and PhD in University College Dublin. He then moved to Innsbruck, Austria working with Prof. Walter Pfaller. In 2009 Paul habilitated in Epithelial Physiology (Venia Docendi).


2009 Habilitation (Venia Docendi) in Physiology at the Division of Physiology, Dept. of Physiology and Medical Physics, Innsbruck Medical University entitled “Epithelial Cell Cultures as tools to study human disease and the adverse effects of pharmaceuticals and chemicals.”

1996 - 2001 PhD fellowship at the Department of Pharmacology, University College Dublin, Ireland. Supervised by Professor Michael P. Ryan, Head of Department. PhD thesis was entitled, “Novel Approaches For In Vitro Nephrotoxicity Testing”.

1992 - 1996 Honours Bachelor of Science Degree, specialising in Pharmacology. University College Dublin, Ireland.

1987 - 1992 Second level education. Moyle Park College, Clondalkin, Dublin 22, Ireland.

1979 - 1987 Primary level education. St. Killians National School, Kingswood Hts. Dublin 24, Ireland.

Ancillary activities

Vice President Nederlandse Vereniging voor Toxicologie (NVT,
Editor in Chief, Toxicology in Vitro (TIV,
Assosciated Editor, Archives of Toxocology (AOT,


Ancillary activities

No ancillary activities

Ancillary activities are updated daily


Dive into the research topics where Paul Jennings is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
  • 1 Similar Profiles


Recent external collaboration on country/territory level. Dive into details by clicking on the dots or